Literature DB >> 22997456

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

B Escudier1, T Eisen, C Porta, J J Patard, V Khoo, F Algaba, P Mulders, V Kataja.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22997456     DOI： 10.1093/annonc/mds227

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  101 in total

Review 1.  The discovery and development of sorafenib for the treatment of thyroid cancer.

Authors:  Peter T White; Mark S Cohen
Journal:  Expert Opin Drug Discov       Date:  2015-02-08       Impact factor: 6.098

2.  Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.

Authors:  Xiaolong Zhang; Xiaopeng Zhang; Tianbao Huang; Jiang Geng; Min Liu; Junhua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.

Authors:  Wenxing Fan; Jie Huang; Hua Xiao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.

Authors:  Anna Maria Ierardi; Alessio Puliti; Salvatore Alessio Angileri; Mario Petrillo; Ejona Duka; Chiara Floridi; Michela Lecchi; Gianpaolo Carrafiello
Journal:  Med Oncol       Date:  2017-04-19       Impact factor: 3.064

Review 5.  The role of surgery for metastatic renal cell carcinoma in the era of targeted therapies.

Authors:  Pierre Bigot; Souhil Lebdai; Alain Ravaud; Abdel Rahmène Azzouzi; Jean-Marie Ferrière; Jean-Jacques Patard; Jean-Christophe Bernhard
Journal:  World J Urol       Date:  2013-03-30       Impact factor: 4.226

Review 6.  Review of renal cell carcinoma and its common subtypes in radiology.

Authors:  Gavin Low; Guan Huang; Winnie Fu; Zaahir Moloo; Safwat Girgis
Journal:  World J Radiol       Date:  2016-05-28

Review 7.  Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting.

Authors:  Guillermo de Velasco; Lana Hamieh; Suzanne Mickey; Toni K Choueiri
Journal:  Urol Oncol       Date:  2015-10-09       Impact factor: 3.498

8.  Utilization of renal mass biopsy in patients with renal cell carcinoma.

Authors:  John T Leppert; Janet Hanley; Todd H Wagner; Benjamin I Chung; Sandy Srinivas; Glenn M Chertow; James D Brooks; Christopher S Saigal
Journal:  Urology       Date:  2014-02-12       Impact factor: 2.649

Review 9.  Pazopanib: a review of its use in the management of advanced renal cell carcinoma.

Authors:  Paul L McCormack
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

10.  Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.

Authors:  Donghao Shang; Tiandong Han; Xiuhong Xu; Yuting Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.